Kochanek P, Schoettle R, Uhl M, Magargee M J, Nemoto E
Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh, Pennsylvania.
J Neurotrauma. 1991 Spring;8(1):19-25. doi: 10.1089/neu.1991.8.19.
Platelet-activating factor (PAF) receptor antagonists reportedly improve early postischemic neurological recovery and cerebral blood flow in selected experimental models. Their effects on posttraumatic cerebral edema have, however, not been examined. In a rat model of right hemispheric percussive cerebral trauma, we examined the effects of two PAF receptor antagonists on posttraumatic edema formation. Two groups of rats received either BN 52021 (n = 14) or WEB 2086 (n = 11), 10 mg/kg i.v. at 15 min posttrauma. Two other groups treated with the BN 52021 (n = 17) and WEB 2086 (n = 10) vehicles served as controls. Hemispheric percent brain water was determined at 24 h. Edema occurred in all groups. Neither PAF receptor antagonist significantly reduced right hemispheric percent brain water (81.08 +/- 0.25 and 81.04 +/- 0.15 in Bn 52021 and WEB 2086-treated rats, respectively, versus 81.31 +/- 0.23 and 81.14 +/- 0.17% brain water in BN 52021 vehicle and WEB 2086 vehicle-treated rats). Mortality was not statistically different between groups. These data do not support a major role for PAF in the development of posttraumatic cerebral edema.
据报道,在特定实验模型中,血小板活化因子(PAF)受体拮抗剂可改善缺血后早期神经功能恢复和脑血流量。然而,它们对创伤后脑水肿的影响尚未得到研究。在大鼠右半球撞击性脑损伤模型中,我们研究了两种PAF受体拮抗剂对创伤后脑水肿形成的影响。两组大鼠在创伤后15分钟静脉注射10mg/kg的BN 52021(n = 14)或WEB 2086(n = 11)。另外两组分别用BN 52021(n = 17)和WEB 2086(n = 10)的溶媒进行处理作为对照。在24小时时测定半球脑含水量百分比。所有组均出现水肿。两种PAF受体拮抗剂均未显著降低右半球脑含水量百分比(BN 52021和WEB 2086处理组大鼠分别为81.08±0.25和81.04±0.15,而BN 52021溶媒组和WEB 2086溶媒组大鼠脑含水量分别为81.31±0.23和81.14±0.17%)。各组间死亡率无统计学差异。这些数据不支持PAF在创伤后脑水肿发展中起主要作用。